Extrahepatic Disease Should Not Preclude Transarterial Chemoembolization for Metastatic Neuroendocrine Carcinoma

被引:0
|
作者
David Arrese
Megan E. McNally
Ravi Chokshi
Enrique Feria-Arias
Carl Schmidt
Dori Klemanski
Guy Gregory
Hooman Khabiri
Manisha Shah
Mark Bloomston
机构
[1] Riverside Methodist Hospital,Department of Surgery
[2] Ohio State University Medical Center,Division of Surgical Oncology
[3] University of Medicine and Dentistry of New Jersey,Department of Surgery
[4] Ohio State University Medical Center,Department of Radiology
[5] Ohio State University Medical Center,Division of Medical Oncology
来源
关键词
Tace; Octreotide; Tumor Burden; Neuroendocrine Carcinoma; Biochemical Response;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1114 / 1120
页数:6
相关论文
共 50 条
  • [21] Transarterial Chemoembolization of Hepatocellular Carcinoma via Extrahepatic Artery from a Right Renal Artery Trunk
    Yang, Haiming
    Li, Ting
    Yan, Jingxin
    INDIAN JOURNAL OF SURGERY, 2022, 84 (SUPPL 2) : 441 - 442
  • [22] Predictors of extrahepatic recurrence after transarterial chemoembolization as first-line therapy for hepatocellular carcinoma
    Pinto, E.
    Pelizzaro, F.
    Vitale, A.
    Giannini, E. G.
    Trevisani, F.
    Farinati, F.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S51 - S52
  • [23] Expanding the therapeutic armamentarium for advanced hepatocellular carcinoma: successful transarterial chemoembolization of peritoneal extrahepatic metastasis
    Brandi, Nicolo
    Giampalma, Emanuela
    Renzulli, Matteo
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2024, 17 (05) : 922 - 927
  • [24] Comparison of the Effects of Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma between Patients with and without Extrahepatic Metastases
    Yoo, Jeong-Ju
    Lee, Jeong-Hoon
    Lee, Sang Hwan
    Lee, Minjong
    Lee, Dong Hyeon
    Cho, Yuri
    Lee, Yun Bin
    Yu, Su Jong
    Kim, Hyo-Cheol
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Kim, Chung Yong
    Lee, Hyo-Suk
    PLOS ONE, 2014, 9 (11):
  • [25] Predictors of extrahepatic recurrence after transarterial chemoembolization as first-line therapy for hepatocellular carcinoma
    Pinto, Elisa
    Pelizzaro, Filippo
    Vitale, Alessandro
    Giannini, Edoardo
    Trevisani, Franco
    Farinati, Fabio
    JOURNAL OF HEPATOLOGY, 2023, 78 : S511 - S512
  • [26] Transarterial Chemoembolization of Hepatocellular Carcinoma via Extrahepatic Artery from a Right Renal Artery Trunk
    Haiming Yang
    Ting Li
    Jingxin Yan
    Indian Journal of Surgery, 2022, 84 : 441 - 442
  • [27] Response Letter to Correspondence Regarding "Chronic Hepatotoxicity in Patients with Metastatic Neuroendocrine Tumor: Transarterial chemoembolization versus transarterial radioembolization"
    Currie, Brian M.
    Nadolski, Gregory
    Soulen, Michael C.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 32 (03) : 483 - 484
  • [28] Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?
    Kitano, Mio
    Davidson, Gail W.
    Shirley, Lawrence A.
    Schmidt, Carl R.
    Guy, Gregory E.
    Khabiri, Hooman
    Dowell, Joshua D.
    Shah, Manisha H.
    Bloomston, Mark
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (12) : 4008 - 4015
  • [29] Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?
    Mio Kitano
    Gail W. Davidson
    Lawrence A. Shirley
    Carl R. Schmidt
    Gregory E. Guy
    Hooman Khabiri
    Joshua D. Dowell
    Manisha H. Shah
    Mark Bloomston
    Annals of Surgical Oncology, 2016, 23 : 4008 - 4015
  • [30] Comparison of Yttirum-90 Microspheres and Transarterial Chemoembolization in the Treatment of Inoperable Metastatic Neuroendocrine Tumors
    Wu, Yuhsin V.
    Tomaszewski, Garin
    Groman, Adrienne E.
    Iyer, Renuka V.
    Kuvshinoff, Boris W.
    PANCREAS, 2013, 42 (02) : 385 - 386